Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Voyage Biomedical was a private medtech startup developing a brain cooling device intended to reduce neurologic injury during stroke and other ischemic events. The company focused on targeted therapeutic hypothermia delivered through a catheter-based system, commonly described as the Voyage Brain Cooling System. Public startup profiles place the company in Berkeley, California, and identify Y Combinator, Berkeley SkyDeck, and Creative Destruction Lab among its backers. Voyage Biomedical appears to have been acquired by Penumbra, after which third-party databases marked it as closed or acquired. It was not a drug-development biotech company, but it was clearly healthcare-related through its neuroprotection and acute care device focus.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Voyage Biomedical.